Global Scleral Lens Market size and share is currently valued at USD 343.45 million in 2024 and is anticipated to generate an estimated revenue of USD 1,035.37 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 14.8% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 β 2032.
The global scleral lens market is experiencing accelerated growth as ophthalmologists and optometrists increasingly adopt these advanced contact lenses for managing a wide range of corneal and ocular surface disorders. Scleral lenses, which are larger in diameter than conventional contact lenses, rest on the sclera (the white part of the eye) and vault over the cornea, creating a fluid-filled reservoir that provides superior comfort, stability, and visual correction for patients with complex eye conditions.
Scleral lenses were once considered niche solutions, primarily used in tertiary eye care centers. However, recent advancements in lens materials, customization technologies, and fitting methodologies have made them more accessible to a broader range of patients. These lenses are now recognized not only for their therapeutic benefits but also for their growing use in vision correction for patients with irregular corneas, severe dry eye syndrome, and post-surgical complications.
Market Overview
Scleral lenses are specially designed rigid gas-permeable (RGP) lenses that provide enhanced comfort and optical performance for individuals with irregular corneal surfaces or advanced ocular surface disease. Unlike standard contact lenses that sit on the cornea, scleral lenses rest on the sclera and create a smooth optical surface over the damaged or distorted cornea. This unique design makes them highly effective in managing conditions such as keratoconus, Stevens-Johnson syndrome, graft-versus-host disease (GVHD), post-LASIK ectasia, and severe dry eye.
The market comprises several types of scleral lenses, including mini-scleral lenses and full-sized lenses, which are tailored to suit various ocular anatomies and clinical needs. Customization has become a key trend, with modern diagnostic tools enabling precise mapping of the ocular surface for optimal lens design and fit. This has led to increased satisfaction among patients and eye care professionals alike.
Scleral lenses are being increasingly prescribed in specialty eye clinics, tertiary referral centers, and even primary optometry practices as knowledge and training expand globally. Technological innovations, growing patient awareness, and enhanced accessibility are transforming the scleral lens landscape from a niche solution to a more mainstream therapeutic and optical option.
Key Market Growth Drivers
- Rising Prevalence of Corneal and Ocular Surface Disorders
The increase in corneal irregularities such as keratoconus, post-surgical corneal ectasia, and complications from refractive surgeries has driven demand for advanced corrective solutions. Scleral lenses offer unmatched stability and visual clarity for these conditions, filling a critical gap in traditional vision correction options. As these disorders become more frequently diagnosed, the need for specialty lenses continues to grow. - Expansion of Applications Beyond Therapeutic Use
While scleral lenses were initially developed for severe ocular surface disease, their applications have expanded to include high refractive errors, astigmatism, and presbyopia. They are now being used in patients who require both functional and cosmetic enhancements, further increasing their appeal. This shift from purely therapeutic to a broader range of optical corrections is boosting adoption rates. - Technological Advancements in Lens Design and Materials
Advancements in gas-permeable lens materials, 3D imaging for ocular surface mapping, and computer-aided design software have revolutionized the fitting and performance of scleral lenses. Newer materials offer higher oxygen permeability, which improves long-term wearability and reduces complications. Enhanced customization ensures that even complex eye anatomies can be successfully fitted, leading to improved clinical outcomes. - Growing Awareness and Training Among Eye Care Professionals
Increased training programs, workshops, and certifications offered by professional associations and manufacturers are equipping more eye care practitioners to prescribe scleral lenses confidently. As knowledge dissemination expands, the number of clinics offering scleral lens fittings has grown, making these lenses more accessible to a wider patient base. - Rising Demand for Non-Surgical Vision Correction
With a global trend toward non-invasive and reversible vision correction options, scleral lenses offer an effective alternative to surgical procedures for many patients. Especially for individuals with contraindications to refractive surgery or those with post-operative complications, scleral lenses provide a viable and safe solution. - Enhanced Patient Outcomes and Quality of Life
Numerous clinical studies have demonstrated that scleral lenses significantly improve quality of life for patients suffering from chronic ocular discomfort and poor vision. Their ability to restore functional vision while providing therapeutic protection to the ocular surface has made them a preferred option for long-term management of debilitating conditions.
Key Companies:
- ABB Optical Group (US)
- Alden Optical Laboratories (US)
- Art Optical Contact Lens Inc. (US)
- Bausch Health Companies Inc. (Canada)
- Blanchard Lab (US)
- BostonSight (US)
- Essilor (France)
- SynergEyes (US)
- TruForm Optics Inc. (US)
- Valley Contax (US)
- Visionary Optics (US)
ππ±π©π₯π¨π«π ππ‘π ππ¨π¦π©π₯πππ ππ¨π¦π©π«ππ‘ππ§π¬π’π―π πππ©π¨π«π πππ«π:
https://www.polarismarketresearch.com/industry-analysis/scleral-lens-market
Polaris Market Research has segmented the scleral lens market report based on type, application, end-user:
Scleral Lens, Type Outlook (RevenueΒ –Β USD Million, 2019 – 2032)
- Corneo-Scleral Lenses
- Semi-Scleral Lenses
- Mini-Scleral Lenses
- Full Scleral Lenses
Scleral Lens, Application Outlook (RevenueΒ –Β USD Million, 2019 – 2032)
- Irregular Cornea
- Ocular Surface Disease
- Refractive Error
- Others
Scleral Lens, End User Outlook (RevenueΒ –Β USD Million, 2019 – 2032)
- Hospitals
- Eye Clinics
- Others
Regional Analysis
North America
North America leads the global scleral lens market, driven by a high prevalence of keratoconus and post-refractive surgery complications, along with well-established eye care infrastructure. The United States, in particular, has seen increased adoption of scleral lenses, supported by clinical research, professional training, and patient education initiatives. Manufacturers in the region are investing in product development and expanding fitting networks to meet growing demand.
Europe
Europe represents a strong market for scleral lenses, with countries such as Germany, the UK, France, and the Netherlands at the forefront of specialty lens innovation. Eye care professionals in the region are increasingly incorporating scleral lenses into routine practice, driven by a robust regulatory framework and patient access to advanced eye care services. Research collaborations between academic institutions and manufacturers also support ongoing development.
Asia-Pacific
The Asia-Pacific region is emerging as a significant growth market due to increasing awareness, urbanization, and rising eye health concerns related to lifestyle and environmental factors. Countries like Japan, South Korea, and Australia have adopted advanced diagnostic technologies that support scleral lens fitting. In developing markets such as India and China, growing investments in optometry education and eye care infrastructure are paving the way for market expansion.
Latin America
Latin America is witnessing gradual but steady growth in the scleral lens market, particularly in countries such as Brazil, Mexico, and Argentina. Increased availability of specialty contact lenses, supported by regional distributors and eye care chains, is enhancing access. Continued education and training will be crucial to fully unlock the region’s market potential.
Middle East and Africa
The Middle East and Africa represent emerging opportunities for scleral lenses. While access remains limited in several areas, countries like the UAE and South Africa are showing increased interest in specialty lenses due to rising incidences of corneal diseases and expanding healthcare capabilities. International partnerships and outreach programs are helping raise awareness and improve clinician capacity.
Future Outlook
The scleral lens market is poised for continued expansion as demand grows for personalized, non-surgical solutions to complex eye conditions. Ongoing improvements in materials, manufacturing precision, and diagnostic imaging are likely to drive further advancements, making fittings more efficient and outcomes more predictable. Manufacturers are expected to focus on expanding accessibility through affordable options, broader practitioner training, and digital fitting technologies.
As the global population ages and awareness of ocular surface disorders increases, scleral lenses are expected to play an increasingly important role in the future of vision care. The shift toward proactive eye health management and patient-centric solutions will further cement scleral lenses as a cornerstone of modern ophthalmology and optometry practice.
In conclusion, the scleral lens market stands at the intersection of therapeutic innovation and personalized care. As it continues to expand in both scope and reach, this market offers promising opportunities for manufacturers, practitioners, and patients alike.
More Trending Latest Reports By Polaris Market Research:
Semiconductor Manufacturing Equipment Market
3D Motion Capture System Market
Point-of-Use Water Treatment Systems Market